Target intelligence / Profile preview

C-type lectin domain family 4 member D (CLEC4D)

Target
CLEC4D
Molecular classification
C-type lectin receptor, Pattern recognition receptor (PRR), Receptor, Immune system receptor, Calcium-dependent lectin
01

Overview

C-type lectin domain family 4 member D (CLEC4D) is a calcium-dependent, type II transmembrane receptor predominantly expressed on myeloid lineage cells, including neutrophils and monocytes[1][2][5]. It functions as a pattern recognition receptor (PRR) in the innate immune system, recognizing both damage-associated (DAMPs) and pathogen-associated (PAMPs) molecular patterns, such as alpha-mannans on fungal pathogens (notably, Candida albicans) and mycobacterial glycolipids like trehalose-6,6'-dimycolate[1][8]. Upon ligand binding, CLEC4D triggers cellular signaling via Syk kinase, leading to phagocytosis, cytokine release, respiratory burst, and the maturation of antigen-presenting cells, thereby promoting adaptive immune responses such as Th1 and Th17 polarization[1][2]. CLEC4D also forms functional complexes with other lectin family members (e.g., CLEC6A/Dectin-2) and is implicated in defense against fungal and some bacterial infections[1]. There are currently no approved or experimental drugs known to target CLEC4D directly; its role is primarily in host defense and immunomodulation[1][8].

Other names
Dectin-3Macrophage C-type lectinMCLCLECSF8CD368MpclC-type lectin superfamily member 8C-type lectin-like receptor 6Dendritic cell-associated C-type lectin 3
02

Mechanism of action

Recognition of microbial glycolipids or carbohydrates triggers downstream signaling via SYK kinase; Promotes cytokine production and immune cell activation

03

Biological functions

Innate immune responsePattern recognition (recognizes DAMPs and PAMPs)PhagocytosisSignal transduction (via Syk kinase)Proinflammatory cytokine productionAntigen uptakeAntigen-presenting cell maturationT helper cell priming (Th1/Th17)Respiratory burst in myeloid cells
04

Disease associations

InfectionFungal infection (such as Candida albicans recognition)Bacterial infection (recognizes mycobacterial components)InflammationChromoblastomycosisSubcutaneous mycosis
05

Safety considerations

Broad immune activation could theoretically lead to excessive inflammation or tissue damage if uncontrolledSpecific safety concerns in a therapeutic context have not been reported in the literature

Beyond the preview

Go deeper on C-type lectin domain family 4 member D (CLEC4D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-type lectin domain family 4 member D (CLEC4D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call